Press Enter to search
Few facilities convert to safety-engineered devices overnight. Contracts expire on different dates, departments carry different budgets, backorders arrive out of sequence, and some procedures keep conventional devices longer than others. The predictable result is a mixed fleet — conventional and safety-engineered devices in use at the same time, sometimes on the same unit and occasionally in the same supply drawer.
That in-between stretch is not a neutral waiting period. It is its own risk window, and it deserves a plan rather than just a purchase order.
Federal rules push facilities toward continuous, incremental adoption rather than a single changeover. Under the OSHA Bloodborne Pathogens Standard, employers must “document annually consideration and implementation of appropriate commercially available and effective safer medical devices.” A yearly evaluation cycle naturally produces staggered adoption: one device category converts this year, another the next.
The exposure is concentrated in everyday procedures. A seven-year review of 355 sharps injuries published in the Journal of International Medical Research found that blood collection was the single most common procedure involved, accounting for 26.5 percent of injuries, ahead of waste collection at 18.3 percent. Routine, high-volume tasks carry the risk, which is also where a conversion has the most to gain.
When both device types sit within arm's reach, staff alternate between two motor patterns during the same shift. The weak point is almost never the device design — it is activation. Active safety devices depend on the user to engage the mechanism, and the American College of Surgeons notes that such devices “require user activation and are therefore more prone to error,” citing previous studies in which activation of active safety devices was as low as 19 percent. The same statement reports that active safety-engineered devices are up to 70 times more likely to be involved in a sharps injury than passive devices.
A device that is never activated offers the protection of a conventional device at a safety device price. During a mixed-fleet period, when habits are still forming, that gap widens.
Because activation is the failure point, the passive-versus-active distinction matters more during a conversion than at any other time. A passive device engages its own protection as part of normal use, so a distracted or rushed clinician still ends up with a shielded sharp. An active device depends on a deliberate step that competes with old habits.
MYCO Medical's catalog carries both approaches, which makes the trade-off easy to evaluate side by side. The RELI® WEALY® Retractable Safety Syringe uses passive activation of needle retraction, eliminating the capping step entirely, and the RELI® WEALY® Retractable Safety Insulin Syringes retract immediately after use. By contrast, the RELI® Safety Hypodermic Needle uses a flip-hinged shield with one-handed activation and bevel orientation, so shield position indicates needle position — a tactile cue that helps the habit form faster.
Prioritizing passive devices for the highest-volume, highest-pressure areas is a reasonable way to spend a conversion budget, since those are the settings where a missed activation step is most likely.
Supply chains tend to convert by product code and delivery date. Clinical risk follows workflow. Sequencing the rollout around how staff actually work shortens the window in which two device types compete for the same hand:
Convert a full unit or procedure at once rather than swapping a percentage of stock everywhere.
Finish one area before opening the next so no department lives in transition indefinitely.
Separate the two device types physically — never in the same drawer, bin, or procedure tray.
Time each conversion to a lower-census period when there is room for coaching at the bedside.
Sweep the outliers — crash carts, procedure rooms, float supply closets, and satellite clinics tend to hold conventional stock long after the main storeroom converts.
Involving clinicians in device selection is both practical and required. The standard directs employers to “solicit input from non-managerial employees responsible for direct patient care who are potentially exposed to injuries from contaminated sharps in the identification, evaluation, and selection of effective engineering and work practice controls,” and to document it.
Treat that requirement as the transition plan rather than a compliance signature. Staff who evaluated a device during trial arrive at go-live already knowing how it activates. For more on building that participation into daily routine, see our guide to building a culture of safety in blood collection.
Where an active device is the right clinical choice, favor designs that make the safe state something a colleague can see or hear rather than something the user has to remember. The RELI® Push Button Safety Blood Collection Set uses one-handed activation with an audible click and a visible indicator arrow, giving immediate confirmation at the point of use. Those cues support the visual check rather than replace it: best practice is still to inspect every device and confirm the safety mechanism is fully engaged before disposal.
Auditing sharps containers during the transition turns activation into a measurable number rather than an assumption. Counting how many devices arrive with the mechanism engaged tells the safety committee whether the rollout is working while there is still time to adjust training. Our overview of how to reduce sharps injuries in hospitals covers the wider program those audits feed.
Some components have to work with whatever is still in circulation. The RELI® Safety Blood Collection Tube Holder is designed for secure use with conventional multiple-sample blood collection needles up to 1-1/2 inches, which matters when needle and holder conversions land on different contract cycles.
Matched product families help for the same reason. Because the RELI® Conventional Hypodermic Needle and its safety counterpart share sizing and connection conventions, a department can convert without relearning gauge and length selection at the same time — one change instead of two.
A mixed fleet ends when the conventional device becomes unavailable, not when the safety device becomes preferred. Set a removal date per area, adjust par levels so the old code cannot be reordered, and physically pull remaining stock rather than letting it drain down. An indefinite transition is the most expensive version of this project: the facility pays safety device prices while retaining conventional device risk. Our breakdown of the total cost of safety walks through how those numbers compare.
MYCO Medical supports facilities through device transitions across needles and syringes and blood collection, with both passive and active safety-engineered options and conventional equivalents for phased conversions. To request complimentary evaluation samples so clinical staff can assess activation before a facility-wide commitment, contact our sales team.
What is a mixed fleet in sharps safety?
A mixed fleet is any period in which conventional and safety-engineered devices are both in active clinical use. It commonly occurs during phased conversions, when contracts for different device categories expire at different times, or when backorders delay part of a rollout.
Is a mixed fleet a compliance problem?
Not automatically. The Bloodborne Pathogens Standard requires employers to document annual consideration and implementation of appropriate, commercially available safer devices. Phased adoption is acceptable, but a transition that stalls without documented justification is harder to defend.
What is the difference between a passive and an active safety device?
A passive device engages its protective mechanism automatically as part of normal use, such as a syringe that retracts its needle on completion. An active device requires the user to perform a deliberate step, such as sliding or flipping a shield into place.
Why do injuries still happen after safety devices are introduced?
Most commonly because the safety mechanism was not engaged. Active devices depend on user activation, and published figures show activation rates far below 100 percent, which is why observable activation cues and container audits matter during a rollout.
Should conversion happen all at once or department by department?
Department by department, converting each area completely before starting the next. Partial conversion spread across many units maximizes the time staff spend switching between two device types, which is the condition most associated with activation error.
How should conventional stock be removed?
Set a removal date for each area, adjust par levels so the conventional item cannot be reordered, and physically pull the remaining inventory from storerooms, procedure carts, and crash carts rather than waiting for it to be used up.
.jpg)
%20(1).png)